FI970858A0 - Tirilasadin parenteraalinen apuliuotinformulaatio - Google Patents
Tirilasadin parenteraalinen apuliuotinformulaatioInfo
- Publication number
- FI970858A0 FI970858A0 FI970858A FI970858A FI970858A0 FI 970858 A0 FI970858 A0 FI 970858A0 FI 970858 A FI970858 A FI 970858A FI 970858 A FI970858 A FI 970858A FI 970858 A0 FI970858 A0 FI 970858A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- parenteral
- tirilazad
- auxiliary solvent
- solvent formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29937094A | 1994-09-01 | 1994-09-01 | |
US38225695A | 1995-02-01 | 1995-02-01 | |
PCT/US1995/010730 WO1996006618A1 (en) | 1994-09-01 | 1995-08-29 | Cosolvent parenteral formulation of tirilazad |
Publications (2)
Publication Number | Publication Date |
---|---|
FI970858A0 true FI970858A0 (fi) | 1997-02-28 |
FI970858A FI970858A (fi) | 1997-02-28 |
Family
ID=26971187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970858A FI970858A (fi) | 1994-09-01 | 1997-02-28 | Tirilasadin parenteraalinen apuliuotinformulaatio |
Country Status (23)
Country | Link |
---|---|
US (1) | US5858999A (cs) |
EP (1) | EP0778775B1 (cs) |
JP (1) | JPH10505063A (cs) |
KR (1) | KR100359556B1 (cs) |
CN (1) | CN1156962A (cs) |
AT (1) | ATE175875T1 (cs) |
AU (1) | AU696856B2 (cs) |
BR (1) | BR9508655A (cs) |
CA (1) | CA2196063A1 (cs) |
CZ (1) | CZ283875B6 (cs) |
DE (1) | DE69507493T2 (cs) |
DK (1) | DK0778775T3 (cs) |
ES (1) | ES2128761T3 (cs) |
FI (1) | FI970858A (cs) |
GR (1) | GR3029396T3 (cs) |
HU (1) | HUT76808A (cs) |
MX (1) | MX9701342A (cs) |
NO (1) | NO311405B1 (cs) |
NZ (1) | NZ292690A (cs) |
PL (1) | PL181244B1 (cs) |
RU (1) | RU2152789C2 (cs) |
SK (1) | SK280278B6 (cs) |
WO (1) | WO1996006618A1 (cs) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
PT1143962E (pt) * | 1999-01-28 | 2005-03-31 | Kurani Shashikant Prabhudas | Solucao parenterica de propofol (2,6-di-isopropilfenol) e 2,5-di-o-metil-1,4;3,6-di-anidro-d-glucitol, como dissolvente |
DE10010073B4 (de) | 2000-02-28 | 2005-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verankerung für implantierbare Herzklappenprothesen |
DE10010074B4 (de) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung zur Befestigung und Verankerung von Herzklappenprothesen |
FR2828263B1 (fr) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | Dispositif d'implantation d'un implant et procede d'implantation du dispositif |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
CA2550459C (en) * | 2003-12-18 | 2009-12-15 | Biomas, Ltd. | Tellurium derivatives for prevention and treatment of neurodegenerative processes |
EP1791535B1 (en) | 2004-09-17 | 2008-07-30 | BioMAS Ltd. | Novel tellurium compounds and their use as immunomodulators |
EP2471536A1 (en) * | 2004-09-29 | 2012-07-04 | Harbor BioSciences, Inc. | Steroid analogs and characterization and treatment methods |
DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
DE102005051849B4 (de) | 2005-10-28 | 2010-01-21 | JenaValve Technology Inc., Wilmington | Vorrichtung zur Implantation und Befestigung von Herzklappenprothesen |
DE102005052628B4 (de) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Selbstexpandierendes, flexibles Drahtgeflecht mit integrierter Klappenprothese für den transvaskulären Herzklappenersatz und ein System mit einer solchen Vorrichtung und einem Einführkatheter |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
WO2008138584A1 (en) | 2007-05-15 | 2008-11-20 | Jenavalve Technology Inc. | Handle for manipulating a catheter tip, catheter system and medical insertion system for inserting a self-expandable heart valve stent |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
US8465540B2 (en) | 2008-02-26 | 2013-06-18 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US8398704B2 (en) | 2008-02-26 | 2013-03-19 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9168130B2 (en) | 2008-02-26 | 2015-10-27 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US8317858B2 (en) | 2008-02-26 | 2012-11-27 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
ES2903231T3 (es) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente |
DK2444092T3 (en) | 2008-05-28 | 2015-09-28 | Reveragen Biopharma Inc | Non-hormonal steroidmodulatorer of NF-? B for the treatment of disease |
US20100292779A1 (en) | 2009-05-15 | 2010-11-18 | Helmut Straubinger | Device for compressing a stent and a system as well as a method for loading a stent into a medical delivery system |
WO2011127048A2 (en) | 2010-04-05 | 2011-10-13 | Validus Biopharma | NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE |
US11278406B2 (en) | 2010-05-20 | 2022-03-22 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
BR112012029896A2 (pt) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | válcula cardíaca protética para endoprótese e endoprótese |
JP6005168B2 (ja) | 2011-10-21 | 2016-10-12 | イエナバルブ テクノロジー インク | 患者の身体への拡張型心臓弁ステント導入用カテーテルシステム、カテーテルシステムを備えた挿入システムおよび心臓弁欠陥治療用医療機器 |
WO2013171007A1 (en) | 2012-05-16 | 2013-11-21 | Jenavalve Technology Gmbh | Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for the treatment of a heart valve defect |
CN103861090B (zh) * | 2012-12-18 | 2017-06-13 | 美迪思生物科技(北京)有限公司 | 含蛋白或多肽的疏水溶液、其制备方法及用途 |
CN105491978A (zh) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | 用于假体瓣膜的径向可折叠框架及其制造方法 |
EP3288495B1 (en) | 2015-05-01 | 2019-09-25 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU195918B (en) * | 1984-03-14 | 1988-08-29 | Jerome Corbiere | Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components |
WO1987001706A2 (en) * | 1985-09-12 | 1987-03-26 | The Upjohn Company | C20 through c26 amino steroids |
US5175281A (en) * | 1985-09-12 | 1992-12-29 | The Upjohn Company | Pharmaceutically active pyrimidinylpiperazinylsterioids |
US4968675A (en) * | 1988-10-28 | 1990-11-06 | Upjohn | Non-hemolytic lazaroid parenteral formulation |
US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
JP2002500616A (ja) * | 1994-07-21 | 2002-01-08 | ファルマシア・アンド・アップジョン・カンパニー | 神経学的に活性なアミノステロイド |
US5614515A (en) * | 1994-11-17 | 1997-03-25 | University Of Southern California | Lazaroid-based compositions and method for preventing adhesion formation using the same |
-
1995
- 1995-08-29 CZ CZ97559A patent/CZ283875B6/cs not_active IP Right Cessation
- 1995-08-29 HU HU9701255A patent/HUT76808A/hu unknown
- 1995-08-29 EP EP95931566A patent/EP0778775B1/en not_active Expired - Lifetime
- 1995-08-29 CN CN95194876A patent/CN1156962A/zh active Pending
- 1995-08-29 AT AT95931566T patent/ATE175875T1/de not_active IP Right Cessation
- 1995-08-29 PL PL95318901A patent/PL181244B1/pl not_active IP Right Cessation
- 1995-08-29 DK DK95931566T patent/DK0778775T3/da active
- 1995-08-29 KR KR1019970701344A patent/KR100359556B1/ko not_active IP Right Cessation
- 1995-08-29 AU AU34938/95A patent/AU696856B2/en not_active Ceased
- 1995-08-29 NZ NZ292690A patent/NZ292690A/en unknown
- 1995-08-29 DE DE69507493T patent/DE69507493T2/de not_active Expired - Fee Related
- 1995-08-29 CA CA002196063A patent/CA2196063A1/en not_active Abandoned
- 1995-08-29 US US08/875,217 patent/US5858999A/en not_active Expired - Fee Related
- 1995-08-29 RU RU97105066/14A patent/RU2152789C2/ru not_active IP Right Cessation
- 1995-08-29 SK SK262-97A patent/SK280278B6/sk unknown
- 1995-08-29 MX MX9701342A patent/MX9701342A/es unknown
- 1995-08-29 BR BR9508655A patent/BR9508655A/pt not_active IP Right Cessation
- 1995-08-29 JP JP8508842A patent/JPH10505063A/ja not_active Withdrawn
- 1995-08-29 ES ES95931566T patent/ES2128761T3/es not_active Expired - Lifetime
- 1995-08-29 WO PCT/US1995/010730 patent/WO1996006618A1/en active IP Right Grant
-
1997
- 1997-02-28 NO NO19970935A patent/NO311405B1/no unknown
- 1997-02-28 FI FI970858A patent/FI970858A/fi not_active IP Right Cessation
-
1999
- 1999-02-12 GR GR990400480T patent/GR3029396T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0778775T3 (da) | 1999-09-13 |
NO970935D0 (no) | 1997-02-28 |
CZ55997A3 (en) | 1997-06-11 |
PL181244B1 (pl) | 2001-06-29 |
ES2128761T3 (es) | 1999-05-16 |
HUT76808A (en) | 1997-11-28 |
CZ283875B6 (cs) | 1998-06-17 |
NO970935L (no) | 1997-04-11 |
DE69507493D1 (de) | 1999-03-04 |
ATE175875T1 (de) | 1999-02-15 |
PL318901A1 (en) | 1997-07-21 |
US5858999A (en) | 1999-01-12 |
AU696856B2 (en) | 1998-09-17 |
AU3493895A (en) | 1996-03-22 |
BR9508655A (pt) | 1997-08-12 |
CN1156962A (zh) | 1997-08-13 |
WO1996006618A1 (en) | 1996-03-07 |
EP0778775A1 (en) | 1997-06-18 |
NO311405B1 (no) | 2001-11-26 |
EP0778775B1 (en) | 1999-01-20 |
GR3029396T3 (en) | 1999-05-28 |
KR100359556B1 (ko) | 2002-12-18 |
NZ292690A (en) | 1998-06-26 |
RU2152789C2 (ru) | 2000-07-20 |
SK26297A3 (en) | 1997-09-10 |
CA2196063A1 (en) | 1996-03-07 |
FI970858A (fi) | 1997-02-28 |
JPH10505063A (ja) | 1998-05-19 |
SK280278B6 (sk) | 1999-10-08 |
DE69507493T2 (de) | 1999-06-10 |
MX9701342A (es) | 1997-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI970858A0 (fi) | Tirilasadin parenteraalinen apuliuotinformulaatio | |
EG20764A (en) | Pharmaceutical emulsion | |
DE69530081T2 (de) | Gastrin- und cck-antagonisten | |
IL124674A0 (en) | Piperazine derivatives pharmaceutical compositions containing the same and use thereof | |
SE9503143D0 (sv) | New preparation | |
GR3023266T3 (en) | 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8a-g(b))-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF. | |
ES2177642T3 (es) | Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis. | |
BR9509975A (pt) | Formulação farmacêutica | |
ATE113056T1 (de) | Künstliche rezeptor-analoge. | |
TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
NO941084D0 (no) | Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner | |
EP0579765A4 (en) | Method and composition for the treatment of herpes related disorders | |
SE9500897D0 (sv) | The pharmacological use of certain cystine derivatives | |
ATE145647T1 (de) | Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen | |
BR9712628A (pt) | Derivados de 8(9)-deidroestradiol | |
NO964921L (no) | Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |